ERIS LIFESCIENCES Quarterly Results
| Consolidated | Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 Audited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 Audited |
Mar2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹807 Cr | ₹792 Cr | ₹773 Cr | ₹705 Cr | ₹727 Cr | ₹741 Cr | ₹720 Cr | ₹551 Cr |
| Expenses | ₹526 Cr | ₹504 Cr | ₹496 Cr | ₹453 Cr | ₹477 Cr | ₹477 Cr | ₹470 Cr | ₹403 Cr |
| Operating Income | ₹282 Cr | ₹288 Cr | ₹277 Cr | ₹252 Cr | ₹250 Cr | ₹265 Cr | ₹250 Cr | ₹148 Cr |
| Other Income | ₹0 Cr | ₹3 Cr | ₹3 Cr | ₹8 Cr | ₹4 Cr | ₹5 Cr | ₹2 Cr | ₹15 Cr |
| Interest | ₹49 Cr | ₹50 Cr | ₹49 Cr | ₹54 Cr | ₹57 Cr | ₹59 Cr | ₹60 Cr | ₹33 Cr |
| Depreciation | ₹70 Cr | ₹69 Cr | ₹71 Cr | ₹77 Cr | ₹81 Cr | ₹80 Cr | ₹76 Cr | ₹54 Cr |
| Profit Before Tax | ₹145 Cr | ₹172 Cr | ₹160 Cr | ₹129 Cr | ₹116 Cr | ₹129 Cr | ₹116 Cr | ₹77 Cr |
| Profit After Tax | ₹109 Cr | ₹134 Cr | ₹124 Cr | ₹102 Cr | ₹87 Cr | ₹96 Cr | ₹90 Cr | ₹80 Cr |
| EPS | ₹7.32 | ₹8.82 | ₹8.66 | ₹6.89 | ₹6.15 | ₹6.73 | ₹6.12 | ₹5.22 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| ERIS LIFESCIENCES | -1.3% | -3.9% | 1.5% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.3% | 3.1% | 2.2% |
| DIVIS LABORATORIES | 0.5% | -2.9% | 5.4% |
| CIPLA | -3.3% | -6.9% | -17% |
| TORRENT PHARMACEUTICALS | 0.1% | 1.4% | 37.6% |
| DR REDDYS LABORATORIES | 1.9% | 1.4% | 10.7% |
| MANKIND PHARMA | -4.4% | -3.6% | -7.9% |
| ZYDUS LIFESCIENCES | 0.5% | -2.1% | -1.9% |
| LUPIN | 1.4% | 4.3% | 13.2% |
ERIS LIFESCIENCES Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 1.90 % |
| Y-o-Y | 11.00 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Dec2025 | ₹807 Cr | 1.90 | |
| Sep2025 | ₹792 Cr | 2.51 | |
| Jun2025 | ₹773 Cr | 9.60 | |
| Mar2025 | ₹705 Cr | -3.04 | |
| Dec2024 | ₹727 Cr | -1.85 | |
| Sep2024 | ₹741 Cr | 2.98 | |
| Jun2024 | ₹720 Cr | 30.64 | |
| Mar2024 | ₹551 Cr | - | |
ERIS LIFESCIENCES Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | -2.29 % |
| Y-o-Y | 12.50 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Dec2025 | ₹282 Cr | -2.29 | |
| Sep2025 | ₹288 Cr | 4.16 | |
| Jun2025 | ₹277 Cr | 9.64 | |
| Mar2025 | ₹252 Cr | 0.83 | |
| Dec2024 | ₹250 Cr | -5.37 | |
| Sep2024 | ₹265 Cr | 5.81 | |
| Jun2024 | ₹250 Cr | 68.43 | |
| Mar2024 | ₹148 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -4.10 % |
| Y-o-Y | 1.37 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Dec2025 | 34.88% | -4.10 | |
| Sep2025 | 36.37% | 1.59 | |
| Jun2025 | 35.8% | 0.06 | |
| Mar2025 | 35.78% | 3.98 | |
| Dec2024 | 34.41% | -3.59 | |
| Sep2024 | 35.69% | 2.76 | |
| Jun2024 | 34.73% | 28.92 | |
| Mar2024 | 26.94% | - | |
ERIS LIFESCIENCES Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | -18.99 % |
| Y-o-Y | 24.87 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Dec2025 | ₹109 Cr | -18.99 | |
| Sep2025 | ₹134 Cr | 8.03 | |
| Jun2025 | ₹124 Cr | 21.43 | |
| Mar2025 | ₹102 Cr | 17.49 | |
| Dec2024 | ₹87 Cr | -9.70 | |
| Sep2024 | ₹96 Cr | 7.66 | |
| Jun2024 | ₹90 Cr | 12.36 | |
| Mar2024 | ₹80 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -20.50 % |
| Y-o-Y | 12.45 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Dec2025 | 13.46 % | -20.50 | |
| Sep2025 | 16.93 % | 5.35 | |
| Jun2025 | 16.07 % | 10.83 | |
| Mar2025 | 14.5 % | 21.14 | |
| Dec2024 | 11.97 % | -7.99 | |
| Sep2024 | 13.01 % | 4.58 | |
| Jun2024 | 12.44 % | -14.03 | |
| Mar2024 | 14.47 % | - | |
ERIS LIFESCIENCES Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | -17.01 % |
| Y-o-Y | 19.02 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Dec2025 | ₹7.32 | -17.01 | |
| Sep2025 | ₹8.82 | 1.85 | |
| Jun2025 | ₹8.66 | 25.69 | |
| Mar2025 | ₹6.89 | 12.03 | |
| Dec2024 | ₹6.15 | -8.62 | |
| Sep2024 | ₹6.73 | 9.97 | |
| Jun2024 | ₹6.12 | 17.24 | |
| Mar2024 | ₹5.22 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD